首页> 外文会议>European Congress of Neurosurgery >Recurrent Pituitary Adenomas
【24h】

Recurrent Pituitary Adenomas

机译:经常性垂体腺瘤

获取原文

摘要

The goals of treatment for all pituitary adenomas include: elimination of mass effect; normalization of hormonal hypersecretion; preservation of normal anterior and posterior pituitary function; and elimination of the potential for recurrence. Of all these goals, the last is the most difficult to achieve, and the management of recurrent pituitary adenomas is the focus of this presentation.Recurrences after surgical management may be related to incomplete removal of the lesion (technically, this is persistence of the tumor) or to recurrence of the basic disease process. Accurate estimates of post-surgical recurrence rates depend upon careful and complete follow-up studies. These include ophthahnological evaluations and determinations of baseline normal pituitary functions for those patients with clinically non-functioning pituitary tumors. These lesions are initially manifest by symptoms of mass effect - visual loss and hypopituitarism, and periodic follow-up studies help to show that the patient remains free of recurrent disease.
机译:所有垂体腺瘤治疗的目标包括:消除质量效应;荷尔蒙乳化的正常化;保存正常的前垂体和后垂体功能;并消除复发潜力。在所有这些目标中,最后是最难以实现的,经常性垂体腺瘤的管理是本介绍的重点。手术治疗后的症状可能与病变不完全去除(技术上,这是肿瘤的持久性)或复发基本疾病过程。准确的手术后复发率估计取决于仔细和完整的后续研究。这些包括对临床非功能性垂体肿瘤患者的基线常脑垂体功能的眼科评估和确定。这些病变最初通过质量效应 - 视觉丧失和低钠缺陷主义的症状表现出,并且定期随访研究有助于表明患者仍然没有复发性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号